Inventor · disambiguated record
Priyam Singh
Also filed as: SINGH PRIYAM
4 granted patents·7 pending applications·10 citations·filing 2016–2024
69Inventor score
Top patents by PatentIndex Score
11 records- 0192US11744846B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2021·Granted Sep 5, 2023·2 cites·14 claims
- 0291US10426789B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·6 cites·23 claims
- 0386US11013758B2Allele specific modulators of P23H rhodopsinIONIS PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·2 cites·10 claims
- 0480US2024401039A1Compounds and Methods for Reducing ATXN2 ExpressionIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0573US2023112920A1Compositions for Modulating C9ORF72 ExpressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0665US2022315923A1Compounds and methods for reducing snca expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0759US2024336915A1Compounds and methods for reducing dux4 expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0856US2023357770A1Compounds and methods for reducing apoe expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0951US11419872B2Phosphoinositide 3-kinase and Src inhibitors for treatment of pancreatic cancerINNOPLEXUS AG·Filed 2020·Granted Aug 23, 2022·0 cites·15 claims
- 1050US2022112503A1Compounds and methods for reducing pmp22 expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1148US2022031731A1Compositions and methods for modulation of lmna expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →